Axcella Health Inc.

NASDAQ:AXLA

4.58 (USD) • At close September 17, 2024
Bedrijfsnaam Axcella Health Inc.
Symbool AXLA
Munteenheid USD
Prijs 4.58
Beurswaarde 0
Dividendpercentage 0%
52-weken bereik 0.36 - 4.58
Industrie Biotechnology
Sector Healthcare
CEO Mr. William R. Hinshaw Jr.
Website https://www.axcellahealth.com

An error occurred while fetching data.

Over Axcella Health Inc.

Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrence;

Vergelijkbare Aandelen

iCAD, Inc. logo

iCAD, Inc.

ICAD

1.74 USD

Aptose Biosciences Inc. logo

Aptose Biosciences Inc.

APTO

0.398 USD

DURECT Corporation logo

DURECT Corporation

DRRX

1.35 USD

Ardelyx, Inc. logo

Ardelyx, Inc.

ARDX

5.89 USD

Aeglea BioTherapeutics, Inc. logo

Aeglea BioTherapeutics, Inc.

AGLE

12.01 USD

LAVA Therapeutics N.V. logo

LAVA Therapeutics N.V.

LVTX

1.77 USD

Trevi Therapeutics, Inc. logo

Trevi Therapeutics, Inc.

TRVI

3.04 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)